These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26492576)

  • 1. Ligand-Orientation Based Fragment Selection in STD NMR Screening.
    Cala O; Krimm I
    J Med Chem; 2015 Nov; 58(21):8739-42. PubMed ID: 26492576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates.
    Angulo J; Enríquez-Navas PM; Nieto PM
    Chemistry; 2010 Jul; 16(26):7803-12. PubMed ID: 20496354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saturation transfer difference NMR spectroscopy as a technique to investigate protein-carbohydrate interactions in solution.
    Haselhorst T; Lamerz AC; Itzstein Mv
    Methods Mol Biol; 2009; 534():375-86. PubMed ID: 19277538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saturation transfer difference nuclear magnetic resonance study on the specific binding of ligand to protein.
    Ji Z; Yao Z; Liu M
    Anal Biochem; 2009 Feb; 385(2):380-2. PubMed ID: 19070584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening.
    Wang YS; Liu D; Wyss DF
    Magn Reson Chem; 2004 Jun; 42(6):485-9. PubMed ID: 15137040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NMR methods for observing protein-ligand interaction].
    Hiroaki H
    Seikagaku; 2013 Aug; 85(8):679-86. PubMed ID: 24050011
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes.
    Jayalakshmi V; Krishna NR
    J Magn Reson; 2002 Mar; 155(1):106-18. PubMed ID: 11945039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR screening in fragment-based drug design: a practical guide.
    Kim HY; Wyss DF
    Methods Mol Biol; 2015; 1263():197-208. PubMed ID: 25618347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring weak ligand-protein interactions by long-lived NMR states: improved contrast in fragment-based drug screening.
    Buratto R; Mammoli D; Chiarparin E; Williams G; Bodenhausen G
    Angew Chem Int Ed Engl; 2014 Oct; 53(42):11376-80. PubMed ID: 25196717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saturation transfer difference NMR for fragment screening.
    Begley DW; Moen SO; Pierce PG; Zartler ER
    Curr Protoc Chem Biol; 2013; 5(4):251-268. PubMed ID: 24391096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
    Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
    J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding Moiety Mapping by Saturation Transfer Difference NMR.
    Brender JR; Krishnamoorthy J; Ghosh A; Bhunia A
    Methods Mol Biol; 2018; 1824():49-65. PubMed ID: 30039401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast Quantitative Validation of 3D Models of Low-Affinity Protein-Ligand Complexes by STD NMR Spectroscopy.
    Nepravishta R; Ramírez-Cárdenas J; Rocha G; Walpole S; Hicks T; Monaco S; Muñoz-García JC; Angulo J
    J Med Chem; 2024 Jun; 67(12):10025-10034. PubMed ID: 38848103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II.
    Wen X; Yuan Y; Kuntz DA; Rose DR; Pinto BM
    Biochemistry; 2005 May; 44(18):6729-37. PubMed ID: 15865418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of 2D Difference Intensity Analysis for Chemical Library Screening by Protein-Detected NMR Spectroscopy.
    Egner JM; Jensen DR; Olp MD; Kennedy NW; Volkman BF; Peterson FC; Smith BC; Hill RB
    Chembiochem; 2018 Mar; 19(5):448-458. PubMed ID: 29239081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the "Three-Finger Pharmacophore" Required for p53-MDM2 Inhibition by Saturation-Transfer Difference (STD) NMR Initial Growth-Rates Approach.
    Angulo J; Goffin SA; Gandhi D; Searcey M; Howell LA
    Chemistry; 2016 Apr; 22(17):5858-62. PubMed ID: 26864212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR studies of protein-ligand interactions.
    Goldflam M; Tarragó T; Gairí M; Giralt E
    Methods Mol Biol; 2012; 831():233-59. PubMed ID: 22167678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.